共 50 条
- [3] Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases [J]. Digestive Diseases and Sciences, 2019, 64 : 1651 - 1659
- [4] Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases [J]. Digestive Diseases and Sciences, 2019, 64 : 3674 - 3675
- [5] Vedolizumab Levels During Induction Are Associated With Remission in Patients With Inflammatory Bowel Diseases [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S353 - S354
- [8] Vedolizumab induction and maintenance though levels and long-term clinical and biochemical status in inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S563 - S564
- [9] Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S362 - S363
- [10] Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease [J]. FRONTIERS IN PEDIATRICS, 2021, 9